Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 238

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

MafB negatively regulates RANKL-mediated osteoclast differentiation

Kim, Kabsun, Kim, Jung Ha, Lee, Junwon, Jin, Hye Mi, Kook, Hyun, Kim, Kyung Keun, Lee, Soo Young, Kim, Nacksung·2007·Blood
DOI 10.1182/blood-2006-09-048249
Open this paper in CoChat — free account

Abstract

Receptor activator of nuclear factor κB ligand (RANKL) induces osteoclast formation from hematopoietic cells via regulation of various transcription factors. Here, we show that MafB negatively regulates RANKL-induced osteoclast differentiation. Expression levels of MafB are significantly reduced by RANKL during osteoclastogenesis. Overexpression of MafB in bone marrow-derived monocyte/macrophage lineage cells (BMMs) inhibits the formation of TRAP+ multinuclear osteoclasts, but phagocytic activity of BMMs is retained. Furthermore, overexpression of MafB in BMMs attenuates the gene induction of NFATc1 and osteoclast-associated receptor (OSCAR) during RANKL-mediated osteoclastogenesis. In addition, MafB proteins interfere with the DNA-binding ability of c-Fos, Mitf, and NFATc1, inhibiting their transactivation of NFATc1 and OSCAR. Furthermore, reduced expression of MafB by RNAi enhances osteoclastogenesis and increases expression of NFATc1 and OSCAR. Taken together, our results suggest that MafB can act as an important modulator of RANKL-mediated osteoclastogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2006-09-048249

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 31

  1. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev1999; 20:345–357. · DOI
  2. Teitelbaum SL. Bone resorption by osteoclasts. Science2000; 289:1504–1508. · DOI · Paper page
  3. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A1998; 95:3597–3602. · DOI
  4. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell1998; 93:165–176. · DOI · Paper page
  5. Teitelbaum SL and Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet2003; 4:638–649. · DOI
  6. Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature2004; 428:758–763. · DOI
  7. Mocsai A, Humphrey MB, Van Ziffle JA, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A2004; 101:6158–6163. · DOI
  8. Ishikawa S, Arase N, Suenaga T, et al. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int Immunol2004; 16:1019–1025. · DOI
  9. Kim N, Takami M, Rho J, Josien R, Choi Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med2002; 195:201–209. · DOI
  10. Merck E, Gaillard C, Gorman DM, et al. OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells. Blood2004; 104:1386–1395. · DOI
  11. Kim K, Kim JH, Lee J, et al. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem2005; 280:35209–35216. · DOI
  12. So H, Rho J, Jeong D, et al. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem2003; 278:24209–24216. · DOI
  13. Kim Y, Sato K, Asagiri M, Morita I, Soma K, Takayanagi H. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem2005; 280:32905–32913. · DOI
  14. Blanchi B, Kelly LM, Viemari JC, et al. MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth. Nat Neurosci2003; 6:1091–1100. · DOI
  15. Blank V and Andrews NC. The Maf transcription factors: regulators of differentiation. Trends Biochem Sci1997; 22:437–441. · DOI
  16. Cordes SP and Barsh GS. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell1994; 79:1025–1034. · DOI
  17. Ring BZ, Cordes SP, Overbeek PA, Barsh GS. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development2000; 127:307–317. · DOI · Paper page
  18. Motohashi H, Shavit JA, Igarashi K, Yamamoto M, Engel JD. The world according to Maf. Nucleic Acids Res1997; 25:2953–2959. · DOI
  19. Eichmann A, Grapin-Botton A, Kelly L, Graf T, Le Douarin NM, Sieweke M. The expression pattern of the mafB/kr gene in birds and mice reveals that the kreisler phenotype does not represent a null mutant. Mech Dev1997; 65:111–122. · DOI
  20. Kelly LM, Englmeier U, Lafon I, Sieweke MH, Graf T. MafB is an inducer of monocytic differentiation. EMBO J2000; 19:1987–1997. · DOI
  21. Lee J, Kim K, Kim JH, et al. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood2006; 107:2686–2693. · DOI
  22. Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol2002; 169:1516–1523. · DOI
  23. Suda T, Jimi E, Nakamura I, Takahashi N. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol1997; 282:223–235. · DOI
  24. Kim N, Kadono Y, Takami M, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med2005; 202:589–595. · DOI
  25. Hotokezaka H, Sakai E, Kanaoka K, et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem2002; 277:47366–47372. · DOI
  26. Kang BY, Chung SW, Im SY, Hwang SY, Kim TS. Chloromethyl ketones inhibit interleukin-12 production in mouse macrophages stimulated with lipopolysaccharide. Immunol Lett1999; 70:135–138. · DOI
  27. Kao SJ, Lei HC, Kuo CT, et al. Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology2005; 115:366–374. · DOI
  28. Woo KJ, Park JW, Kwon TK. Proteasome inhibitor-induced cyclooxygenase-2 expression in Raw264.7 cells is potentiated by inhibition of c-Jun N-terminal kinase activation. Biochem Biophys Res Commun2006; 342:1334–1340. · DOI
  29. Mansky KC, Sankar U, Han J, Ostrowski MC. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem2002; 277:11077–11083. · DOI
  30. Matsushima-Hibiya Y, Nishi S, Sakai M. Rat maf-related factors: the specificities of DNA binding and heterodimer formation. Biochem Biophys Res Commun1998; 245:412–418. · DOI
  31. Moriguchi T, Hamada M, Morito N, et al. MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol2006; 26:5715–5727. · DOI

Cited by

See all 238

Metadata

Authors
Kim, K., Kim, J. H., Lee, J., Jin, H. M., Kook, H., Kim, K. K., Lee, S. Y., & Kim, N.
Affiliations
  • Research Institute of Medical Sciences and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju, Korea;
  • Division of Molecular Life Sciences and Center for Cell Signaling Research, Ewha Womans University, Seoul, Korea
Venue
Blood
Publisher
American Society of Hematology
Published
2006-12-07
Volume
109
Issue
8
Pages
3253-3259
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood-2006-09-048249
Cited by
238
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.